ÂÜÀòÂÒÂ×

Dr. Mirmira is a Professor and Director of the Translational Research Center at the University of Chicago. He is an expert in the biology of the pancreatic islet as it relates to the pathogeneses of type 1 and type 2 diabetes. Dr. Mirmira’s team showed that 12-lipoxygenase contributes to islet oxidative stress in the setting of diabetes, and that the deletion or inhibition of 12-lipoxygenase in islets of mice enhances insulin secretion and prevents hyperglycemia. He has published more than 130 scientific papers in prestigious journals and is an international thought leader in the field of diabetes. Dr. Mirmira received an MD/PhD from The University of Chicago and completed his residency in Internal Medicine with subspecialty training in Diabetes and Endocrinology at the University of California at San Francisco.